1. Complement anaphylatoxins C3a and C5a: Emerging roles in cancer progression and treatment
   Daniel Ajona et al, 2019, Seminars in Cell & Developmental Biology CrossRef
2. Value of the pretreatment albumin to globulin ratio in predicting long-term mortality in breast cancer patients
   Basem N. Azab et al, 2013, The American Journal of Surgery CrossRef
3. Biomarker discovery and clinical proteomics
   Jerzy Silberring et al, 2010, TrAC Trends in Analytical Chemistry CrossRef
4. The Application of SELDI‐TOF‐MS in Clinical Diagnosis of Cancers
   Chibo Liu et al, 2011, BioMed Research International CrossRef
5. Advances in Proteomic Technologies and Its Contribution to the Field of Cancer
   Mehdi Mesri, 2014, Advances in Medicine CrossRef
6. Ultra-sensitive high performance liquid chromatography–laser-induced fluorescence based proteomics for clinical applications
   Ajeetkumar Patil et al, 2015, Journal of Proteomics CrossRef
7. Up‐regulated Proteins in the Fluid Bathing the Tumour Cell Microenvironment as Potential Serological Markers for Early Detection of Cancer of the Breast
   Pavel Gromov et al, 2010, Molecular Oncology CrossRef
8. Protein Conformational Changes in Breast Cancer Sera Using Infrared Spectroscopic Analysis
   Hemendra Ghimire et al, 2020, Cancers CrossRef
9. Oncoproteomics: insight into current proteomic technologies in cancer biomarker discovery and treatment
   Shrestha Dutta et al, 2022, Journal of Proteins and Proteomics CrossRef
10. Protein Analytical Assays for Diagnosing, Monitoring, and Choosing Treatment for Cancer Patients
    Alicia D. Powers et al, 2012, Journal of Healthcare Engineering CrossRef
11. Identification of Serum Protein Markers for Breast Cancer Relapse With SELDI‐TOF MS
    Lei Lei et al, 2011, The Anatomical Record CrossRef
12. Identification of novel serum peptides biomarkers for female breast cancer patients in Western China
    Juan Yang et al, 2016, PROTEOMICS CrossRef
13. Sensitive liquid chromatography/tandem mass spectrometry assay for absolute quantification of ITIH4‐derived putative biomarker peptides in clinical serum samples
    Irene van den Broek et al, 2010, Rapid Communications in Mass Spectrometry CrossRef
14. Proteomic approaches in myeloid leukemia
    Jitendra Kumar Kanaujiya et al, 2011, ELECTROPHORESIS CrossRef
15. Isolation and Discovery of Small Peptides as Potential Biomarkers in Three Rice Cultivars Using Surface-Enhanced Laser Desorption/Ionization (SELDI) Time-of-Flight (TOF) Mass Spectrometry (MS)
    Yong Ho Lee et al, 2021, Journal of Plant Biology CrossRef
16. Mass spectrometry of peptides and proteins from human blood
    Peihong Zhu et al, 2011, Mass Spectrometry Reviews CrossRef
17. Serum and saliva protein levels in females with breast cancer
    SABAH ISA AL-MUHTASEB, 2014, Oncology Letters CrossRef
18. Serum Level of Fibrinogen A.ALPHA. Chain Fragment Increases in Chronic Thromboembolic Pulmonary Hypertension
    Toshiaki Yano et al, 2011, Circulation Journal CrossRef
19. Large-Scale Analysis of Breast Cancer-Related Conformational Changes in Proteins Using SILAC-SPROX
    Fang Liu et al, 2017, Journal of Proteome Research CrossRef
20. The absolute quantification of eight inter‐α‐trypsin inhibitor heavy chain 4 (ITIH4)‐derived peptides in serum from breast cancer patients
    Irene van den Broek et al, 2010, PROTEOMICS – Clinical Applications CrossRef
21. Protein Biomarkers for the Early Detection of Breast Cancer
    David E. Misek et al, 2011, International Journal of Proteomics CrossRef
22. Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study
    Annemieke WJ Opstal-van Winden et al, 2011, BMC Cancer CrossRef
23. How has proteomics informed transfusion biology so far?
    Giancarlo Liumbruno et al, 2010, Critical Reviews in Oncology/Hematology CrossRef
24. Single-Cell RNA Sequencing Reveals a Dynamic Stromal Niche That Supports Tumor Growth
    Sarah Davidson et al, 2020, Cell Reports CrossRef